PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
- Disease/Condition
- Head and Neck Cancer
- Drug/Device/Intervention
- Lung Cancer Screening Education
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- University of Miami
- Location
- Miami, United States of America
- Phase
- N/A
- Start date
- Dec 31, 2023
- End date
- Dec 31, 2025
- Enrollment
- 44 participants
Proportion of participants' awareness of the risk of second primary lung cancer as measured by the University of Miami lung cancer screening program survey questionnaire.,Proportion of participants' awareness of lung cancer screening recommendations as measured by the University of Miami lung cancer screening program survey questionnaire.,Proportion of participants' perception of the risk of second primary lung cancer as measured by the University of Miami lung cancer screening program survey questionnaire.,Proportion of participants' perception of lung cancer screening recommendations as measured by the University of Miami lung cancer screening program survey questionnaire.
The purpose of this study is to assess the awareness of eligibility of lung cancer screening
 in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to
 understand the barriers to screening using qualitative interviews.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06124508
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06124508 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Miami and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 44 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.